Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
55 Cards in this Set
- Front
- Back
1st gen sulfonylureas end w/
|
"amide"
|
|
2nd gen sulfonlylureas end w/
|
"G...ide"
|
|
Meglitinides end w/
|
"glinide"
|
|
Bigaunides end w/
|
Metformin
|
|
Thiazolidinediones end w/
|
"glitazone"
|
|
a-glucosidase inhibitors
|
acarbose
miglitol |
|
insulin lispro (humalog)
|
ultra short acting insulin
|
|
insulin aspart (novolog) [BCF]
|
ultra short acting insulin
|
|
insulin glulisine
|
ultra short acting insulin (approved for CSII pumps)
|
|
regular insulin (novolin) [BCF]
|
short acting insulin
|
|
only insulin that can be give IV or IM
|
regular insulin (novolin)
|
|
isophane insulin suspension (NPH)
|
intermediate acting insulin
|
|
NPH humulin
|
intermediate acting insulin
|
|
NPH novolin [BCF]
|
intermediate acting insulin
|
|
insulin glargine (lantus) [BCF]
|
long acting insulin
|
|
onset, peak, and duration for ultra short acting insulin
|
15 min
1-2 hrs 4 hrs |
|
onset, peak, and duration for short acting insulin
|
0.5-1 hr
2-4 hrs 8 hrs |
|
onset, peak, and duration for intermediate acting insulin
|
2 hrs
8 hrs 24 hrs |
|
onset, peak, and duration for long acting insulin
|
NA
NA 24 hrs |
|
acetohexamide (dymelor)
|
1st gen sulfonylurea
|
|
chlorpropamide (diabinese)
|
1st gen sulfonylurea
|
|
tolazamide (tolinase)
|
1st gen sulfonylurea
|
|
tolbutamide (orinase)
|
1st gen sulfonylurea
|
|
1st gen sulfonylurea w/ an extremely long half-life
|
chlorpropamide (may cause hypoglycemia)
|
|
glipizide (glucotrol) [BCF]
|
2nd gen sulfonylurea
|
|
glyburide (diabeta/micronase) [BCF]
|
2nd gen sulfonylurea
|
|
glimepiride (amaryl)
|
2nd gen sulfonylurea
|
|
most potent 2nd gen sulfonylurea
|
glimepiride
|
|
2nd gen sulfonylurea not used if CrCl <50ml/min
|
glyburide
|
|
2nd gen sulfonylurea not used if CrCl <10ml/min
|
glipizide
|
|
2nd gen sulfonylurea rx to elderly
|
glipizide
|
|
repaglinide (prandin)
|
meglitinide
|
|
nateglinide (starlix)
|
meglitinide
|
|
antidiabetic agent used for pts w/ varying eating schedules
|
meglitinide
|
|
metformin (glucophage) [BCF]
|
biguanide
|
|
antidiabetic agent used for obese pts
|
biguanide (metformin)
|
|
absolute CI for metformin use
|
SCr >1.5mg/dL
|
|
pioglitazone (actos)
|
thiazolidinediones
|
|
rosiglitazone (avandia) [BCF]
|
thiazolidinediones
|
|
CI for thiazolidinediones use
|
class III/IV heart failure and hepatic dysfunction;
do not start if baseline LFTs >2.5 ULN |
|
will thiazolidinediones work w/ type I diabetes?
|
no...must have insulin on board to work
|
|
acarbose (precose)
|
a-glucosidase inhibitors
|
|
miglitol (glyset)
|
a-glucosidase inhibitors
|
|
CI for a-glucosidase inhibitors
|
GI dysfunctions
|
|
SE of a-glucosidase inhibitors
|
GI disturbances (> carbs = > disturbances)
|
|
which combination antidiabetic agent requires LFTs at baseline and q 2 mos x1 yr?
|
rosiglitazone/metformin (avandamet) [BCF]
|
|
how tx HbA1C at 7%?
|
TLC
|
|
how tx HbA1C at 7-8%?
|
single oral agent
|
|
how tx HbA1C at 9-10%?
|
two or more oral agents
|
|
which antidiabetic drug not given to elderly?
|
metformin because of renal function (SCr >1.5mg/dL)
|
|
what is only acceptable antidiabetic drug for pregnancy?
|
insulin
|
|
when do you add insulin tx to type II diabetes pts?
|
after two drugs if not effective
|
|
diabetic ketoacidosis common in which type?
|
type I
|
|
hyperosmolar nonketotic syndrome (HNKS) common in which type?
|
type II
|
|
what glucose levels expected in HNKS?
|
>600mg/dL
|